PCSA Company Profile and Key Details

Q: Who are the executives of PCSA?

Ms. Wendy J. GuyCo-Founder, Chief Admin. Officer & Corporation Sec.Mr. Patrick LinCo-Founder, Chief Bus. & Strategy OfficerMr. Robert Michael FloydChief Operating OfficerDr. Sian E. Bigora Ph.D., Pharm.D.Co-Founder and Chief Devel. & Regulatory OfficerMr. James H. StankerChief Financial OfficerDr. David Young Ph.D., Pharm.D.Co-Founder, Pres, Chief Executive Officer & DirectorMr. George K. Ng Esq., J.D.Chief Executive Officer & Director

NASDAQ : PCSA

Processa Pharmaceuticals

$2.68

0.13+5.10%

At Close 4:00 PM

57.23

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Processa Pharmaceuticals, Inc. (PCSA) stock surged +5.10%, trading at $2.68 on NASDAQ, up from the previous close of $2.55. The stock opened at $2.69, fluctuating between $2.64 and $2.69 in the recent session.

Stock Snapshot

2.55

Prev. Close

6.07M

Market Cap

2.64

Day Low

-0.25

P/E Ratio

-10.73

EPS (TTM)

-6.27

Cash Flow per Share

2.69

Open

2.27M

Number of Shares

2.69

Day High

84.5%

Free Float in %

3.88

Book Value

24.36K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 04, 2026	2.74	2.75	2.64	2.68	24.38K
Apr 30, 2026	2.64	2.89	2.61	2.70	12.98K
Apr 29, 2026	2.84	2.94	2.57	2.65	72.1K
Apr 28, 2026	2.93	2.96	2.85	2.85	22.76K
Apr 27, 2026	3.07	3.10	2.97	2.99	11.97K
Apr 23, 2026	3.11	3.14	2.98	2.99	19.99K
Apr 22, 2026	2.82	3.27	2.77	3.07	190.04K
Apr 21, 2026	2.80	2.93	2.71	2.77	60.32K
Apr 20, 2026	3.31	3.45	2.71	2.71	149.12K
Apr 17, 2026	3.21	3.45	3.00	3.10	90.65K
Apr 16, 2026	2.95	3.30	2.82	3.18	135.37K
Apr 14, 2026	2.88	2.88	2.73	2.87	20.3K
Apr 13, 2026	2.72	2.91	2.72	2.87	35.92K
Apr 10, 2026	2.98	2.98	2.74	2.77	35.88K
Apr 09, 2026	2.96	3.14	2.86	2.97	49.77K
Apr 08, 2026	2.87	3.02	2.73	3.02	51.32K
Apr 07, 2026	2.86	2.94	2.59	2.87	67.03K
Apr 06, 2026	2.88	3.15	2.68	2.80	264.17K
Apr 02, 2026	2.87	3.22	2.55	2.77	192.9K
Apr 01, 2026	2.51	2.73	2.51	2.60	14.11K

Contact Details

Hanover, MD 21076

United States

https://www.processapharmaceuticals.com 443 776 3133

About Company

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company is also developing PCS12852, a novel selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist that is in Phase 2A clinical trials for the treatment of gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia; PCS3117, a cytosine analog, which is in Phase 2B clinical trials for the treatment of pancreatic and non-small cell lung cancer; and PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase that is in Phase 1B clinical trials for treating metastatic colorectal and breast cancer. In addition, it develops PCS11T, an analog of SN38 and irinotecan drug for the treatment of various cancers. The company was incorporated in 2011 and is based in Hanover, Maryland.

Stock Peers

ARGX

27.59+3.52%

argenx SE$811.09 REGN

7.79+1.11%

Regeneron Pharmaceuticals, Inc.$709.21 UTHR

10.82+1.90%

United Therapeutics Corporation$581.22 MDGL

4.94002+0.96%

Madrigal Pharmaceuticals, Inc.$518.66 VRTX

5.93+1.40%

Vertex Pharmaceuticals Incorporated$429.85 PRAX

13.41+4.14%

Praxis Precision Medicines, Inc.$337.61 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

1.815+0.61%

Alnylam Pharmaceuticals, Inc.$297.93 KRYS

20.91+7.86%

Krystal Biotech, Inc.$286.95 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Processa Pharmaceuticals, Inc. (PCSA) stock price?

Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) stock price is $2.68 in the last trading session. During the trading session, PCSA stock reached the peak price of $2.69 while $2.64 was the lowest point it dropped to. The percentage change in PCSA stock occurred in the recent session was 5.1% while the dollar amount for the price change in PCSA stock was $0.13.

PCSA's industry and sector of operation?

The NASDAQ listed PCSA is part of Biotechnology industry that operates in the broader Healthcare sector. Processa Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PCSA?

Ms. Wendy J. Guy
Co-Founder, Chief Admin. Officer & Corporation Sec.
Mr. Patrick Lin
Co-Founder, Chief Bus. & Strategy Officer
Mr. Robert Michael Floyd
Chief Operating Officer
Dr. Sian E. Bigora Ph.D., Pharm.D.
Co-Founder and Chief Devel. & Regulatory Officer
Mr. James H. Stanker
Chief Financial Officer
Dr. David Young Ph.D., Pharm.D.
Co-Founder, Pres, Chief Executive Officer & Director
Mr. George K. Ng Esq., J.D.
Chief Executive Officer & Director

How PCSA did perform over past 52-week?

PCSA's closing price is 52.27% higher than its 52-week low of $1.76 where as its distance from 52-week high of $19.63 is -86.34%.

How many employees does PCSA have?

Number of PCSA employees currently stands at 10.

Link for PCSA official website?

Official Website of PCSA is: https://www.processapharmaceuticals.com

How do I contact PCSA?

PCSA could be contacted at phone 443 776 3133 and can also be accessed through its website. PCSA operates from 7380 Coca Cola Drive, Hanover, MD 21076, United States.

How many shares of PCSA are traded daily?

PCSA stock volume for the day was 24.36K shares. The average number of PCSA shares traded daily for last 3 months was 51.76K.

What is the market cap of PCSA currently?

The market value of PCSA currently stands at $6.07M with its latest stock price at $2.68 and 2.27M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	10
Beta	0.89
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	10
Beta	0.89
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PCSA Company Profile and Key Details

Processa Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics